BCL2L1 and neoplasm: Consequently, downregulation of the anti-apoptotic gene products BCL2/BCL-XL/XIAP via NF-κB inhibition may allow tumor cells to be sensitive to apoptosis induction by low doses of TMZ, as is the case for U251 showing strongly potentiated apoptosis despite being resistant to single treatments.